Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice

Infection and Immunity

Volumn 76, Issue 11, 2008, Pages 5139-5148

  Andreasen, Charlotte ^a,b   Carbonetti, Nicholas H ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; PERTUSSIS TOXIN; PROTEIN KC; PROTEIN LIX; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL VIRULENCE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; LUNG ALVEOLUS MACROPHAGE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BORDETELLA PERTUSSIS; CHEMOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED BALB C; NEUTROPHIL INFILTRATION; NEUTROPHILS; PERTUSSIS TOXIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WHOOPING COUGH;

EID: 55849101099     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00895-08     Document Type: Article

References (51)

1. Ausiello, C. M., F. Urbani, A. La Sala, R. Lande, A. Piscitelli, and A. Cassone. 1997. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis. Dev. Biol. Stand. 89:315-320.
2. Barnard, A., B. P. Mahon, J. Watkins, K. Redhead, and K. H. Mills. 1996. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0. Immunology 87:372-380.
3. Brito, G. A., M. H. Souza, A. A. Melo-Filho, E. L. Hewlett, A. A. Lima, C. A. Flores, and R. A. Ribeiro. 1997. Role of pertussis toxin A subunit in neutrophil migration and vascular permeability. Infect. Immun. 65:1114-1118.
4. Carbonetti, N. H. 2007. Immunomodulation in the pathogenesis of Bordetella pertussis infection and disease. Curr. Opin. Pharmacol. 7:272-278.
5. Carbonetti, N. H., G. V. Artamonova, C. Andreasen, and N. Bushar. 2005. Pertussis toxin and adenylate cyclase toxin provide a one-two punch for establishment of Bordetella pertussis infection of the respiratory tract. Infect. Immun. 73:2698-2703.
6. Carbonetti, N. H., G. V. Artamonova, C. Andreasen, E. Dudley, R. M. Mays, and Z. E. Worthington. 2004. Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein. Infect. Immun. 72:3350-3358.
7. Carbonetti, N. H., G. V. Artamonova, R. M. Mays, and Z. E. Worthington. 2003. Pertussis toxin plays an early role in respiratory tract colonization by Bordetella pertussis. Infect. Immun. 71:6358-6366.
8. Carbonetti, N. H., G. V. Artamonova, N. Van Rooijen, and V. I. Ayala. 2007. Pertussis toxin targets airway macrophages to promote Bordetella pertussis infection of the respiratory tract. Infect. Immun. 75:1713-1720.
9. Carbonetti, N. H., R. M. Mays, G. V. Artamonova, R. D. Plaut, and Z. E. Worthington. 2005. Proteolytic cleavage of pertussis toxin S1 subunit is not essential for its activity in mammalian cells. BMC Microbiol. 5:7.
10. Chen, X., O. M. Howard, and J. J. Oppenheim. 2007. Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells. J. Immunol. 178:6123-6129.
11. Collier, A. M., L. P. Peterson, and J. B. Baseman. 1977. Pathogenesis of infection with Bordetella pertussis in hamster tracheal organ culture. J. Infect. Dis. 136(Suppl.):S196-S203.
12. Cortese, M. M., A. L. Baughman, K. Brown, and P. Srivastava. 2007. A "new age" in pertussis prevention new opportunities through adult vaccination. Am. J. Prev. Med. 32:177-185.
13. Fedele, G., M. Nasso, F. Spensieri, R. Palazzo, L. Frasca, M. Watanabe, and C. M. Ausiello. 2008. Lipopolysaccharides from Bordetella pertussis and Bordetella parapertussis differently modulate human dendritic cell functions resulting in divergent prevalence of Th17-polarized responses. J. Immunol. 181:208-216.
14. Ferlito, M., O. G. Romanenko, K. Guyton, S. Ashton, F. Squadrito, P. V. Halushka, and J. A. Cook. 2002. Implication of Gα i proteins and Src tyrosine kinases in endotoxin-induced signal transduction events and mediator production. J. Endotoxin Res. 8:427-435.
15. Guiso, N., C. Capiau, G. Carletti, J. Poolman, and P. Hauser. 1999. Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines. Vaccine 17:2366-2376.
16. Harvill, E. T., P. A. Cotter, and J. F. Miller. 1999. Pregenomic comparative analysis between Bordetella bronchiseptica RB50 and Bordetella pertussis Tohama I in murine models of respiratory tract infection. Infect. Immun. 67:6109-6118.
17. Hewlett, E. L. 1997. Pertussis: current concepts of pathogenesis and prevention. Pediatr. Infect. Dis. J. 16:S78-S84.
18. Jakway, J. P., and A. L. DeFranco. 1986. Pertussis toxin inhibition of B cell and macrophage responses to bacterial lipopolysaccharide. Science 234:743-746.
19. Kimura, A., K. T. Mountzouros, P. A. Schad, W. Cieplak, and J. L. Cowell. 1990. Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen. Infect. Immun. 58:3337-3347.
20. Kirimanjeswara, G. S., L. M. Agosto, M. J. Kennett, O. N. Bjornstad, and E. T. Harvill. 2005. Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J. Clin. Investig. 115:3594-3601.
21. Lavigne, M. V., M. Castro, N. Mateo, S. Deluchi, C. Atzori, L. Piudo, M. Calcagno, M. L. Brero, and M. Manghi. 2002. Whole-cell Bordetella pertussis vaccine component modulates the mouse immune response to an unrelated soluble antigen. Microbes Infect. 4:815-820.
22. Lenz, D. H., C. L. Weingart, and A. A. Weiss. 2000. Phagocytosed Bordetella pertussis fails to survive in human neutrophils. Infect. Immun. 68:956-959.
23. Mann, P. B., D. Wolfe, E. Latz, D. Golenbock, A. Preston, and E. T. Harvill. 2005. Comparative Toll-like receptor 4-mediated innate host defense to Bordetella infection. Infect. Immun. 73:8144-8152.
24. Martino, A., E. Volpe, G. Auricchio, V. Colizzi, and P. M. Baldini. 2006. Influence of pertussis toxin on CD1a isoform expression in human dendritic cells. J. Clin. Immunol. 26:153-159.
25. Mascart, F., V. Verscheure, A. Malfroot, M. Hainaut, D. Pierard, S. Temerman, A. Peltier, A. S. Debrie, J. Levy, G. Del Giudice, and C. Locht. 2003. Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses. J. Immunol. 170:1504-1509.
26. Matsuzaki, G., and M. Umemura. 2007. Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol. Immunol. 51:1139-1147.
27. Mills, K. H., M. Ryan, E. Ryan, and B. P. Mahon. 1998. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect. Immun. 66:594-602.
28. Moss, J., S. J. Stanley, D. L. Burns, J. A. Hsia, D. A. Yost, G. A. Myers, and E. L. Hewlett. 1983. Activation by thiol of the latent NAD glycohydrolase and ADP-ribosyltransferase activities of Bordetella pertussis toxin (islet-activating protein). J. Biol. Chem. 258:11879-11882.
29. Nicod, L. P. 1999. Pulmonary defence mechanisms. Respiration 66:2-11.
30. Opremcak, L. B., and M. S. Rheins. 1983. Scanning electron microscopy of mouse ciliated oviduct and tracheal epithelium infected in vitro with Bordetella pertussis. Can. J. Microbiol. 29:415-420.
31. Pero, R. S., M. T. Borchers, K. Spicher, S. I. Ochkur, L. Sikora, S. P. Rao, H. Abdala-Valencia, K. R. O'Neill, H. Shen, M. P. McGarry, N. A. Lee, J. M. Cook-Mills, P. Sriramarao, M. I. Simon, L. Birnbaumer, and J. J. Lee. 2007. Gαi2-mediated signaling events in the endothelium are involved in controlling leukocyte extravasation. Proc. Natl. Acad. Sci. USA 104:4371-4376.
32. Pittman, M., B. L. Furman, and A. C. Wardlaw. 1980. Bordetella pertussis respiratory tract infection in the mouse: pathophysiological responses. J. Infect. Dis. 142:56-66.
33. Plaut, R. D., and N. H. Carbonetti. 2008. Retrograde transport of pertussis toxin in the mammalian cell. Cell. Microbiol. 10:1130-1139.
34. Rambow-Larsen, A. A., and A. A. Weiss. 2002. The PtlE protein of Bordetella pertussis has peptidoglycanase activity required for Ptl-mediated pertussis toxin secretion. J. Bacteriol. 184:2863-2869.
35. Rollins, B. J. 1997. Chemokines. Blood 90:909-928.
36. Rybin, V. O., B. D. Uhal, L. A. Russo, and D. E. Rannels. 1991. ADP ribosylation of type II pulmonary epithelial cell G proteins. Am. J. Physiol. 260:L539-L547.
37. Sato, Y., K. Izumiya, H. Sato, J. L. Cowell, and C. R. Manclark. 1980. Aerosol infection of mice with Bordetella pertussis. Infect. Immun. 29:261-266.
38. Schaeffer, L. M., and A. A. Weiss. 2001. Pertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes. Infect. Immun. 69:7635-7641.
39. Scott, S. J., C. V. Olson, and P. M. Lad. 1988. Peptide mapping studies of the pertussis toxin substrate in human neutrophils, platelets and erythrocytes. Mol. Immunol. 25:305-311.
40. Spangrude, G. J., F. Sacchi, H. R. Hill, D. E. Van Epps, and R. A. Daynes. 1985. Inhibition of lymphocyte and neutrophil chemotaxis by pertussis toxin. J. Immunol. 135:4135-4143.
41. Strieter, R. M., S. L. Kunkel, and T. J. Standiford. 2003. Chemokines in the lung, vol. 172. Marcel Dekker, Inc., New York, NY.
42. Tateda, K., T. A. Moore, M. W. Newstead, W. C. Tsai, X. Zeng, J. C. Deng, G. Chen, R. Reddy, K. Yamaguchi, and T. J. Standiford. 2001. Chemokine-dependent neutrophil recruitment in a murine model of Legionella pneumonia: potential role of neutrophils as immunoregulatory cells. Infect. Immun. 69:2017-2024.
43. Teruya, H., F. Higa, M. Akamine, C. Ishikawa, T. Okudaira, K. Tomimori, N. Mukaida, M. Tateyama, K. Heuner, J. Fujita, and N. Mori. 2007. Mechanisms of Legionella pneumophila-induced interleukin-8 expression in human lung epithelial cells. BMC Microbiol. 7:102.
44. Thomazzi, S. M., M. H. Souza, A. A. Melo-Filho, E. L. Hewlett, A. A. Lima, and R. A. Ribeiro. 1995. Pertussis toxin from Bordetella pertussis blocks neutrophil migration and neutrophil-dependent edema in response to inflammation. Braz. J. Med. Biol. Res. 28:120-124.
45. Tsai, W. C., R. M. Strieter, B. Mehrad, M. W. Newstead, X. Zeng, and T. J. Standiford. 2000. CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect. Immun. 68:4289-4296.
46. Weiss, A. A., and M. S. Goodwin. 1989. Lethal infection by Bordetella pertussis mutants in the infant mouse model. Infect. Immun. 57:3757-3764.
47. Wilson, R., R. Read, M. Thomas, A. Rutman, K. Harrison, V. Lund, B. Cookson, W. Goldman, H. Lambert, and P. Cole. 1991. Effects of Bordetella pertussis infection on human respiratory epithelium in vivo and in vitro. Infect. Immun. 59:337-345.
48. Worthington, Z. E., and N. H. Carbonetti. 2007. Evading the proteasome: absence of lysine residues contributes to pertussis toxin activity by evasion of proteasome degradation. Infect. Immun. 75:2946-2953.
49. Zepp, F., M. Knuf, P. Habermehl, H. J. Schmitt, C. Meyer, R. Clemens, and M. Slaoui. 1997. Cell-mediated immunity after pertussis vaccination and after natural infection. Dev. Biol. Stand. 89:307-314.
50. Zhang, X., and D. C. Morrison. 1993. Lipopolysaccharide-induced selective priming effects on tumor necrosis factor alpha and nitric oxide production in mouse peritoneal macrophages. J. Exp. Med. 177:511-516.
51. Zhang, X., and D. C. Morrison. 1993. Pertussis toxin-sensitive factor differentially regulates lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production in mouse peritoneal macrophages. J. Immunol. 150:1011-1018.